Viewing StudyNCT06371417



Ignite Creation Date: 2024-05-06 @ 8:24 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06371417
Status: RECRUITING
Last Update Posted: 2024-07-08
First Post: 2024-04-04

Brief Title: Phase 1b Trial of RAY121 in Immunological Diseases RAINBOW Trial
Sponsor: Chugai Pharmaceutical
Organization: Chugai Pharmaceutical

Conditions & Keywords Data

Conditions:
Name
Antiphospholipid Syndrome APS
Bullous Pemphigoid BP
Behçets Syndrome BS
Dermatomyositis DM
Immune-mediated Necrotizing Myopathy IMNM
Immune Thrombocytopenia ITP
Keywords: